| abstract |
The present disclosure provides for the administration of TGF-? or a TGF-? derivative to treat and/or prevent a variety of disease states and/or conditions, characterized by the cytokine response of immature intestinal epithelial cells to mucosal injury, bacterial invasion, bacterial antigens and/or products, including, but not limited to, NEC. Furthermore, the present disclosure provides for a pharmaceutical composition and medicaments comprising a therapeutically effective amount of TGF-? or a TGF-? derivative for use in the methods described herein. |